KLDO (Kaleido Biosciences) Accounts Payable: $5.67 Mil (As of Dec. 2021)


What is Kaleido Biosciences Accounts Payable?

Kaleido Biosciences KLDO Accounts Payable is $5.67 Mil as of Dec. 2021.

Kaleido Biosciences's Accounts Payable for the quarter that ended in Dec. 2021 was $5.67 Mil.

Kaleido Biosciences's quarterly Accounts Payable increased from Jun. 2021 ($2.70 Mil) to Sep. 2021 ($3.56 Mil) and increased from Sep. 2021 ($3.56 Mil) to Dec. 2021 ($5.67 Mil).

Kaleido Biosciences's annual Accounts Payable increased from Dec. 2019 ($2.02 Mil) to Dec. 2020 ($5.39 Mil) and increased from Dec. 2020 ($5.39 Mil) to Dec. 2021 ($5.67 Mil).

Kaleido Biosciences Accounts Payable Related Terms

Kaleido Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Accounts Payable Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Accounts Payable
Get a 7-Day Free Trial 0.86 3.44 2.02 5.39 5.67

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.39 2.41 2.70 3.56 5.67

Kaleido Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $5.67 Mil mean?
Kaleido Biosciences (KLDO) has a Accounts Payable of $5.67 Mil as of Dec. 2021. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Accounts Payable too high?
Kaleido Biosciences' current Accounts Payable is $5.67 Mil.
How does Kaleido Biosciences' Accounts Payable compare to NPTX and GSTC?
Kaleido Biosciences' Accounts Payable of $5.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Accounts Payable is $5.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Accounts Payable of $5.67 Mil. The current Accounts Payable is $5.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Accounts Payable is $5.67 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.